(R)-Gossypol is safe and well tolerated in glioblastoma and lymphoma patients in phase II trials June 9, 2009
Additive antitumor activity seen with oncolytic measles virus and bevacizumab in glioma model June 9, 2009
German regulator clears Silence Therapeutics' CTA for phase I study of ATU-027 in cancer June 5, 2009
RSS